First-In-Human Phase 1 Study Of Abbv-085, An Antibody-Drug Conjugate (Adc) Targeting Lrrc15, In Sarcomas And Other Advanced Solid Tumors.George D. Demetri,Jason J. Luke,Antoine Hollebecque,John D. Powderly,Alexander I. Spira,Vivek Subbiah,Dominic W. Lai,Huibin Yue,Sreeneeranj Kasichayanula,Scott Gulbranson,James Purcell, Melinda Myzak,Randy Robinson,Victor Manuel Villalobos,Anthony W. TolcherJOURNAL OF CLINICAL ONCOLOGY（2019）引用 16|浏览26暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
